Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
about
Molecular mechanism of action of metformin: old or new insights?Mulberry therapy for type 2 diabetes mellitusDiabetes mellitus and metformin in hepatocellular carcinomaDrug-Induced Metabolic AcidosisSomething old, something new and something very old: drugs for treating type 2 diabetesTreating the elderly diabetic patient: special considerationsSystematic reviews to ascertain the safety of diabetes medicationsDiabetic kidney disease: a report from an ADA Consensus ConferenceUpdate on the treatment of type 2 diabetes mellitusMetformin and metabolic diseases: a focus on hepatic aspectsMetformin as a cellular protector; a synoptic view of modern evidencesMetformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice.Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report.AMPK activation--protean potential for boosting healthspan.Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.Oral antihyperglycemic therapy for type 2 diabetes mellitus.Metformin is not associated with lactic acidosis in patients with diabetes undergoing coronary artery bypass graft surgery: a case control study.Medication safety and chronic kidney disease in older adults prescribed metformin: a cross-sectional analysis.Management of diabetes mellitus in patients with chronic kidney diseaseBerberine protects against metformin-associated lactic acidosis in induced diabetes mellitus.Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.Metformin-associated acute kidney injury and lactic acidosis.Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.Metformin in patients with type 2 diabetes and kidney disease: a systematic review.Metformin-induced lactic acidosis: no one left behindUse of Metformin in Patients with Kidney and Cardiovascular Diseases.Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City.Medical complications of obesity and optimization of the obese patient for colorectal surgery.Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.Metformin initiation and renal impairment: a cohort study in Denmark and the UKAnti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing DialysisEffectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register.Association between Use of Oral Anti-Diabetic Drugs and the Risk of Sepsis: A Nested Case-Control StudyClinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosisImproving postapproval drug safety surveillance: getting better information soonerPharmacotherapy for childhood obesity: present and future prospects.Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?Lactic Acidosis in Diabetic Population: Is Metformin Implicated? Results of a Matched Case-Control Study Performed on the Type 2 Diabetes Population of Grenoble Hospital University
P2860
Q22252798-AFCC2FE9-4377-4711-A2D7-0B792F43C3AEQ24188271-78E5B496-EFA6-4C76-85DB-DA3B9F8BB3E4Q26741205-D5119998-FFE6-4012-A403-14E94D549464Q26766204-CE5363AC-BD3A-461B-873A-AC63C39FDACCQ26865663-27779F26-E816-40E6-84A4-2A876042F9EFQ26995176-B5DCB658-92A2-4C13-BB76-CEE071823183Q27000766-E91F59A3-FCB4-49CA-956A-5F86D30BBE94Q27012546-68A2CB20-CC7B-474D-B047-E765B18F576EQ28073342-38A4847D-0BD1-4CD7-8A95-A978BE4C2BD4Q28082736-8689B60B-DF99-4646-B68D-4EA5DF0EC771Q28817196-143E377E-9720-4C12-A74B-85419D60D085Q30419141-7E6C75A0-965B-46BB-8C6F-D24E81DAEF79Q33673122-79E15B42-6885-4094-842A-A5BDD129E795Q33689169-53B908F2-255F-402C-B9A7-B925A1C5EAB8Q33705903-817895D6-56C1-455C-B2BA-E5EE62D02ED2Q33713451-9BB4DF66-E4B6-45E1-8224-7305612D023BQ33743721-23A12906-2B94-4B63-893B-8372CD4DF6F6Q33754865-71D26759-0E49-4AC5-917B-9FB7AF452779Q33792375-EB62F9B7-BF31-4771-9941-55F7C02A33E6Q33819586-DEA6417E-5623-4F60-A086-CDDB51406913Q34457919-6FDE7E0F-947F-434F-92DF-19E3CF88BAF7Q34563587-B1E22793-A76F-4D06-8375-424ECDB9B3E1Q35116393-4DAFBC2C-5F34-43F3-959C-65036F01AFD2Q35496697-F49CD608-2A03-4B0A-9A12-130D362566C9Q35533239-D92E274E-9627-4D2D-8E27-079000997055Q35567151-F5E0ED8C-4E04-41E6-AE10-2B52F6603129Q35688570-D622538A-4C27-4B29-B800-7C9A02AC55F1Q35832130-5A787892-92E7-44DF-BA78-A8A13D936074Q35850150-A6A388EC-5AC9-4241-B61F-C516442D5A56Q35922734-DAAE035A-27D0-445F-8D33-2F9994B671E3Q36038990-A05F716F-39E1-4D1C-AAEC-01F207130B7EQ36101262-8395B2EA-2B64-451D-A720-A5D0E0204326Q36103818-67A899FC-6AFF-4119-992E-606D7151F733Q36158762-5851D662-B34A-420F-8D3E-CB04B254F555Q36240156-FBFD632D-17CB-42C1-8A0F-BDB009BC4DA9Q36275299-8CED192B-CFB3-479B-B69C-83AB712CAF95Q36367834-0AAA4727-7825-4AC5-989E-EC993B5B4AD5Q36468087-F1F4E1AC-0AF4-4D64-BB85-5FB89B57F695Q36531654-1E2D650A-BA6E-4F16-9BD6-C2A5D591F31EQ36680984-0F1C4A1E-ABF5-4412-8148-DE6ED27AC4BD
P2860
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@ast
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en-gb
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@nl
type
label
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@ast
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en-gb
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@nl
prefLabel
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@ast
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en-gb
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@nl
P2093
P2860
P3181
P1476
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
@en
P2093
Edwin E Salpeter
Elizabeth Greyber
Gary A Pasternak
Shelley R Salpeter
P2860
P3181
P356
10.1002/14651858.CD002967.PUB4
P577
2010-04-14T00:00:00Z